| MEIP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MEIP shares outstanding history going back to 12/19/2012:
Also see: MEIP Market Cap History MEIP YTD Return |
MEIP Shares Outstanding History — MEI Pharma Share Count Over Time
As of 5/2/2025 MEI Pharma has 6.66 million MEIP shares outstanding. Investors often track the MEIP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MEIP share count trends over time, with 50 historical shares outstanding datapoints presented, dating back to 12/19/2012.
| MEIP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MEIP Historical Shares Outstanding: +33.86% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MEIP Stock Price Chart |
| About Lite Strategy Inc |
| MEI Pharma, Inc. is a clinical-stage pharmaceutical company, which is engaged in developing novel and differentiated cancer therapies. Co.'s drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and ME-344, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway. Voruciclib has completed a Phase I trial evaluating dose and schedule in patients with acute myeloid leukemia (AML) in combination with the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax (marketed as Venclexta). We show 50 historical shares outstanding datapoints in our coverage of MEIP's shares outstanding history. Understanding the changing numbers of MEIP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MEIP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MEIP by allowing them to research MEIP shares outstanding history as well as any other stock in our coverage universe. |
| MEIP Current Stock Quote |
Quotes delayed 20 minutes  Free MEIP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| MEIP Share Performance |
| Shares Outstanding Peers |
| MEI Pharma (MEIP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MGEN Shares Outstanding History MGLN Shares Outstanding History MGNX Shares Outstanding History MGRM Shares Outstanding History MGTA Shares Outstanding History MGX Shares Outstanding History MIRA Shares Outstanding History MIRM Shares Outstanding History MIRO Shares Outstanding History MLAB Shares Outstanding History More Healthcare companies » |
MEIP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
